APA

Gopal S., Lane R., Nuamah I., Copenhaver M., Singh J., Hough D., Bach M. & Savitz A. (20180629). Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study. : CNS drugs.

Chicago

Gopal Srihari, Lane Rosanne, Nuamah Isaac, Copenhaver Margaret, Singh Jaskaran, Hough David, Bach Mark and Savitz Adam. 20180629. Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study. : CNS drugs.

Harvard

Gopal S., Lane R., Nuamah I., Copenhaver M., Singh J., Hough D., Bach M. and Savitz A. (20180629). Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study. : CNS drugs.

MLA

Gopal Srihari, Lane Rosanne, Nuamah Isaac, Copenhaver Margaret, Singh Jaskaran, Hough David, Bach Mark and Savitz Adam. Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study. : CNS drugs. 20180629.